Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


The Impact of Clinical Trials in Tennessee


 
Sen. Mark Green, MD, discusses the importance of local clinical trials and biopharmaceutical research in Tennessee. Pictured (L-R) James and Josi Felts, Dr. Paul Newhouse, Dr. Jeffrey Conn, and Sen. Mark Green.

On Jan. 23, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report that finds there are more than 945 active clinical trials in the Tennessee. Additionally, the report said the life science industry supports 52,000 jobs and contributes $11.7 billion to the state's economy.

"Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in Tennessee," was released at an event held at the Cordell Hull Building, which featured a panel discussion by Vanderbilt University Medical Center biotech researchers, Tennessee State Senator Mark Green, MD, (R-22), and a local Alzheimer's disease patient and clinical trial participant.

"Clinical trials offer patients novel medical treatments while also allowing biopharma research organizations to innovate and grow," said Green, founder of Align MD. "Across the state - and particularly here in Nashville - the healthcare industry has had a profound impact on our economy."

In the United States, there are more than 7,000 open clinical trials being sponsored by the biopharmaceutical industry, universities, individuals and organizations. In Tennessee, active trials are studying treatment options for more than 20 disease sites or types, with cancer trials leading the way by a large margin. Of the 945 open clinical trials involving the biopharmaceutical research industry, Vanderbilt is collaborating on more than 245 of them. In addition, the report cites Meharry Medical College, Sarah Cannon, Clinical Research Associates, Tennessee Clinical Research Center, Tennessee Oncology, Tennessee Retina, and all of the city's major hospitals and health systems as active participants in Nashville.

"Many top universities call Tennessee home and are centers of innovation," said Jeffrey Conn, PhD, director of the Vanderbilt Center for Neuroscience Drug Discovery. "Maintaining strong partnerships between medical universities and life science companies allows us to foster developments right here in Tennessee that can then help save lives far beyond our state lines."

On average, it takes approximately a decade for new medicines to go through the FDA approval process, and only 12 percent of drugs successfully make it through clinical trials. Since 2004, biopharmaceutical research companies have conducted more than 6,100 clinical trials in Tennessee.

The complete report is available online at NashvilleMedicalNews.com

WEB:

Research in Your Backyard Report

 
Share:

Related Articles:


Recent Articles

ACEP Statement on Texas High School Shooting

WASHINGTON -- In response to the high school shooting today in Santa Fe, Texas, Dr. Paul Kivela, president of the American College of Emergency Physicians (ACEP) issued the following statement:

Read More

AMA Marks Milestone in Medical Education As First Students Graduate Under Transformative National Curricula Redesign Initiative

First medical students who received training under national effort begin to graduate this month, including students from NYU, Indiana University, East Carolina University, Oregon Health and Science University, Penn State

Read More

Study Tracks Impact of Neonatal Abstinence Syndrome on State Medicaid Programs 

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.

Read More

Read More

ACEP Board To Consider Further Legal Recourse During May Meeting

The federal government last week published a notice of clarification in response to a court order requiring it to adequately address comments and proposals made by the American College of Emergency Physicians (ACEP) and other organizations regarding the Greatest of Three Rule.

Read More

National Nurses Week: Lipscomb Prepares Next Generation of Servant Nurses

Every day nurses play a significant role in the nation's healthcare, and this week the nation is celebrating the profession as part of the American Nurses Association annual National Nurses Week celebration.

Read More

Healing Mind & Body

Experts say screenings, education, early intervention key to improving, maintaining mental health.

Read More

Searching for Sustainable Solutions to the Physician Shortage

AAMC calls for a multi-pronged approach to address the looming physician shortage.

Read More

Statement On Opioid Related Legislation

America's hospitals and health systems have been engaged in treating people with substance use disorders for decades. In recent years, we have seen first-hand the devastating effects of the opioid epidemic on patients, families, and communities across the country.

Read More

New Legislation Addressing the Opioid Crisis

As the latest session of the Tennessee Legislature drew to a close, new laws were passed impacting the prescribing of opioids, particularly in regards to 'opioid naïve' patients.

Read More

Email Print
 
 

 

 


Tags:
Biopharmaceutical Research, Clinical Trials, Jeffrey Conn, Life Sciences, Mark Green, Pharmaceutical Research and Manufacturers of America, Pharmaceuticals, PhRMA, Research in Your Backyard, Vanderbilt
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: